Search

everythinglearnresearchcommunity

for

Search:↓

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Five FDA-approved drugs may help block COVID-19 virus entry.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.